Derivation and validation of genome-wide polygenic score for urinary tract stone diagnosis.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
11 2020
Historique:
received: 21 12 2019
revised: 30 03 2020
accepted: 16 04 2020
pubmed: 17 6 2020
medline: 22 6 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

Urinary tract stones have high heritability indicating a strong genetic component. However, genome-wide association studies (GWAS) have uncovered only a few genome wide significant single nucleotide polymorphisms (SNPs). Polygenic risk scores (PRS) sum cumulative effect of many SNPs and shed light on underlying genetic architecture. Using GWAS summary statistics from 361,141 participants in the United Kingdom Biobank, we generated a PRS and determined association with stone diagnosis in 28,877 participants in the Mount Sinai BioMe Biobank. In BioMe (1,071 cases and 27,806 controls), for every standard deviation increase, we observed a significant increment in adjusted odds ratio of a factor of 1.2 (95% confidence interval 1.13-1.26). In comparison, a risk score comprised of GWAS significant SNPs was not significantly associated with diagnosis. After stratifying individuals into low and high-risk categories on clinical risk factors, there was a significant increment in adjusted odds ratio of 1.3 (1.12-1.6) in the low- and 1.2 (1.1-1.2) in the high-risk group for every standard deviation increment in PRS. In a 14,348-participant validation cohort (Penn Medicine Biobank), every standard deviation increment was associated with a significant adjusted odds ratio of 1.1 (1.03 - 1.2). Thus, a genome-wide PRS is associated with urinary tract stones overall and in the absence of known clinical risk factors and illustrates their complex polygenic architecture.

Identifiants

pubmed: 32540406
pii: S0085-2538(20)30641-4
doi: 10.1016/j.kint.2020.04.055
pmc: PMC7606592
mid: NIHMS1603591
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1323-1330

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL085757
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM124836
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG009610
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139865
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007278
Pays : United States
Organisme : CSRD VA
ID : IK2 CX001780
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007205
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK108803
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK116100
Pays : United States
Organisme : ACL HHS
ID : U01OH011326
Pays : United States
Organisme : NIOSH CDC HHS
ID : U01 OH011326
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK112258
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK107908
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 International Society of Nephrology. All rights reserved.

Références

Transl Psychiatry. 2017 Nov 30;7(11):1264
pubmed: 29187730
BMJ. 1990 May 12;300(6734):1234-6
pubmed: 2354291
Neurol Genet. 2018 Dec 03;4(6):e293
pubmed: 30584597
J Am Soc Nephrol. 2010 Oct;21(10):1641-4
pubmed: 20616170
JAMA. 2012 Jun 20;307(23):2557
pubmed: 22797461
Circ Cardiovasc Genet. 2017 Oct;10(5):
pubmed: 29030403
Kidney Int. 2005 Sep;68(3):1230-5
pubmed: 16105055
J Urol. 2010 Jul;184(1):190-2
pubmed: 20478584
AMIA Annu Symp Proc. 2014 Nov 14;2014:907-16
pubmed: 25954398
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
Adv Urol. 2018 Feb 4;2018:3068365
pubmed: 29515627
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Am J Hum Genet. 2015 Oct 1;97(4):576-92
pubmed: 26430803
Nat Rev Nephrol. 2011 Dec 20;8(3):151-62
pubmed: 22183508
Am J Psychiatry. 2012 Dec;169(12):1309-17
pubmed: 23212062
J Am Soc Nephrol. 2018 Jun;29(6):1731-1740
pubmed: 29748329
Pediatr Nephrol. 2010 May;25(5):831-41
pubmed: 19198886
Eur Urol. 2012 Jul;62(1):160-5
pubmed: 22498635
Clin J Am Soc Nephrol. 2009 Apr;4(4):804-11
pubmed: 19339425
Nature. 2016 Oct 12;538(7624):161-164
pubmed: 27734877
Nat Rev Dis Primers. 2016 Feb 25;2:16008
pubmed: 27188687
J Urol. 1981 Oct;126(4):424-30
pubmed: 7288928
Am Fam Physician. 2011 Dec 1;84(11):1234-42
pubmed: 22150656
J Am Soc Nephrol. 2015 Mar;26(3):507-10
pubmed: 25296720
Lancet. 2015 Aug 8;386(9993):509-10
pubmed: 26049251

Auteurs

Ishan Paranjpe (I)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The BioMe Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Noah Tsao (N)

Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Renae Judy (R)

Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Manish Paranjpe (M)

Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts, USA.

Kumardeep Chaudhary (K)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The BioMe Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Derek Klarin (D)

Malcolm Randall Veterans Affairs Medical Center, Gainesville, Florida, USA; Division of Vascular Surgery and Endovascular Therapy, University of Florida College of Medicine, Gainesville, Florida, USA; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

Iain Forrest (I)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Ross O'Hagan (R)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The BioMe Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Arjun Kapoor (A)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

John Pfail (J)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Suraj Jaladanki (S)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The BioMe Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Fayzan Chaudhry (F)

The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Akhil Vaid (A)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Phan Q Duy (PQ)

Medical Scientist Training Program, Yale University School of Medicine, New Haven, Connecticut, USA.
The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Regeneron Genetics Center, Tarrytown, New York, USA.

John Cijiang He (JC)

Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Renal Program, James J Peters Veterans Affairs Medical Center at Bronx, New York, New York, USA.

Benjamin S Glicksberg (BS)

The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Steven G Coca (SG)

Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Mantu Gupta (M)

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Ron Do (R)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The BioMe Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Scott M Damrauer (SM)

Department of Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Girish N Nadkarni (GN)

The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The BioMe Phenomics Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA; The Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Renal Program, James J Peters Veterans Affairs Medical Center at Bronx, New York, New York, USA. Electronic address: girish.nadkarni@mountsinai.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH